ArticleOncology letters2016

Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC.

Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.